Biotech | October 27, 2021
Novavax files for approval of its Covid-19 vaccine in the UK
Filing marks first protein-based vaccine submitted to MHRA for authorization
Filing marks first protein-based vaccine submitted to MHRA for authorization
Support from DFC will help produce one billion vaccine doses by the end of 2022
Key takeaways of recent quarter & conference call highlights
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
The acquisition complements and strengthens Merck’s cardiovascular pipeline
The investment will increase SpeeDx internal capacity to scale up manufacturing
Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals and is part of its Digital Access to Care Initiative
First participants enrolled in Phase 1 clinical trial of combination NanoFlu/NVX-CoV2373 vaccine with Matrix-M adjuvant. The Phase 1/2 study will also evaluate immunogenicity and safety
Subscribe To Our Newsletter & Stay Updated
